Even Slight Rise in One Gut Microbe Might Keep You Out of the Hospital
By Dennis Thompson HealthDay Reporter
MONDAY, March 25, 2024 -- Even a slight rise in a specific type of beneficial gut bacteria can help people ward off serious infections, a new study reports.
For every 10% increase in butyrate-producing bacteria in a patient’s gut, their risk of hospitalization for infection drops between 14% and 25%, researchers are scheduled to report at a major European medical meeting next month.
Butyrate is a fatty acid produced by “good” gut bacteria as it breaks down and ferments fiber.
Butyrate pays an important role in digestive system health by providing about 70% of the energy needed by colon cells, according to the Cleveland Clinic.
This new study shows that butyrate also appears to support a person’s immune system, helping fight off infections, researchers said.
They decided to pursue this inquiry after noting that levels of butyrate-producing gut bacteria are commonly depleted in patients hospitalized for severe infections.
Butyrate also appears to have protective effects for several intestinal diseases outside infections, researchers said in background notes.
To study its potential protective effects against illness, researchers analyzed gut microbes from nearly 10,700 people in The Netherlands and Finland. Of those, a little more than 600 died from infections, mainly pneumonia.
The analysis revealed that for every 10% increase in butyrate-producing bacteria, there was a 25% lower risk of hospitalization for infection among the Dutch participants and a 14% lower risk for the Finnish folks.
“Gut microbiome composition, specifically colonization with butyrate-producing bacteria, is associated with protection against hospitalization for infectious diseases in the general population across two independent European cohorts,” concluded the researchers, who were led by Dr. Robert Kullberg of the Amsterdam University Medical Center in The Netherlands.
“Further studies should investigate whether modulation of the microbiome can reduce the risk of severe infections,” the researchers added.
Unfortunately, butyrate-producing bacteria cannot tolerate oxygen, which makes it difficult to get these valuable bacteria into the gut, researchers noted.
This findings are to be presented during a scheduled meeting April 27-30 of the European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain.
Findings presentation at medical meetings are considered preliminary until published in a peer-reviewed journal.
Sources
- European Society of Clinical Microbiology and Infectious Diseases, news release, March 22, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Parental Deaths to Guns, Drugs Harmed Nearly 100,000 U.S. Kids in 2020
MONDAY, May 6, 2024 -- Nearly 100,000 U.S. children lost a parent in 2020 to gun violence or drug overdose, a three-fold rise since 1999, according to a new study. Overall, these...
Parents of Infants With Cystic Fibrosis Often Feel Confused, Unsupported: Survey
MONDAY, May 6, 2024 -- Parents of newborns diagnosed with cystic fibrosis often are confused about both the disease and their next steps, a new national survey has found. In...
Avoid Some 'Project Watson' Dog Eye Wipes Due to Infection Danger
MONDAY, May 6, 2024 -- Pets and pet owners who come into contact with Bausch & Lomb's "Project Watson" dog eye wipes could be at risk for infection if the products come from...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
